英夫利昔单抗治疗与伊匹单抗相关的结肠炎——信函 - Suppr

Infliximab for IPILIMUMAB-Related Colitis-Letter.

作者信息

Arriola Edurne, Wheater Matthew, Karydis Ioannis, Thomas Gareth, Ottensmeier Christian

机构信息

Southampton NIHR Experimental Cancer Medicine Centre, Faculty of Medicine, University of Southampton Tremona Road, Southampton, United Kingdom. University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, United Kingdom.

University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, United Kingdom.

出版信息

Clin Cancer Res. 2015 Dec 15;21(24):5642-3. doi: 10.1158/1078-0432.CCR-15-2471.

DOI:10.1158/1078-0432.CCR-15-2471

PMID:26672088

Abstract

摘要

相似文献

Infliximab for IPILIMUMAB-Related Colitis-Letter.

Clin Cancer Res. 2015 Dec 15;21(24):5642-3. doi: 10.1158/1078-0432.CCR-15-2471.

Infliximab Therapy for Corticosteroid-Resistant Ipilimumab-Induced Colitis.

J Gastrointestin Liver Dis. 2015 Sep;24(3):274. doi: 10.15403/jgld.2014.1121.243.bwp.

Ipilimumab-induced colitis in patients with metastatic melanoma.

Melanoma Res. 2015 Aug;25(4):321-7. doi: 10.1097/CMR.0000000000000165.

Early administration of infliximab for severe ipilimumab-related diarrhea in a critically ill patient.

Ann Pharmacother. 2014 Jun;48(6):806-10. doi: 10.1177/1060028014528152. Epub 2014 Mar 20.

Colitis associated with biological agents.

Dig Dis Sci. 2014 Jun;59(6):1112-4. doi: 10.1007/s10620-014-3147-x.

Ipilimumab-induced acute severe colitis treated by infliximab.

Melanoma Res. 2013 Jun;23(3):227-30. doi: 10.1097/CMR.0b013e32835fb524.

Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis.

World J Gastroenterol. 2017 Mar 21;23(11):2023-2028. doi: 10.3748/wjg.v23.i11.2023.

Autoimmune Colitis and Subsequent CMV-induced Hepatitis After Treatment With Ipilimumab.

J Immunother. 2015 Jun;38(5):212-5. doi: 10.1097/CJI.0000000000000081.

Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab.

Cancer Immunol Res. 2015 Oct;3(10):1185-92. doi: 10.1158/2326-6066.CIR-15-0102. Epub 2015 Jun 22.

Ipilimumab-induced toxicities and the gastroenterologist.

J Gastroenterol Hepatol. 2015 Apr;30(4):657-66. doi: 10.1111/jgh.12888.

引用本文的文献

Impact of steroid-sparing immunosuppressive agents on tumor outcome in the context of cancer immunotherapy with highlight on melanoma: a systematic literature review and meta-analysis.

Front Immunol. 2024 Dec 16;15:1499478. doi: 10.3389/fimmu.2024.1499478. eCollection 2024.

The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic Review.

J Cancer. 2023 Sep 11;14(16):2956-2963. doi: 10.7150/jca.87335. eCollection 2023.

Immunosuppression for immune-related adverse events during checkpoint inhibition: an intricate balance.

NPJ Precis Oncol. 2023 May 12;7(1):41. doi: 10.1038/s41698-023-00380-1.

Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis.

Biologics. 2022 Aug 5;16:119-127. doi: 10.2147/BTT.S367675. eCollection 2022.

The (re)discovery of tumor-intrinsic determinants of immune sensitivity by functional genetic screens.

Immunooncol Technol. 2021 Oct 28;11:100043. doi: 10.1016/j.iotech.2021.100043. eCollection 2021 Oct.

Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer.

Molecules. 2022 Jun 13;27(12):3798. doi: 10.3390/molecules27123798.

Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events.

J Thorac Oncol. 2021 Oct;16(10):1759-1764. doi: 10.1016/j.jtho.2021.06.024. Epub 2021 Jul 12.

Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab.

J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002742.

Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy.

Cancers (Basel). 2021 Feb 2;13(3):564. doi: 10.3390/cancers13030564.

Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy).

J Transl Med. 2021 Jan 6;19(1):13. doi: 10.1186/s12967-020-02627-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Infliximab for IPILIMUMAB-Related Colitis-Letter.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献